| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +30% |
| 3Y CAGR | +10% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | -31% |
| 3Y CAGR | +7.0% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,705.00 +1.20 (0.03%) | 21,500.75 | 29.25 | 5.12 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,547.10 +29.90 (1.19%) | 19,125.30 | 28.21 | 5.33 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹7,035.00 -71.50 (1.01%) | 17,765.63 | 104.73 | 20.35 | ||
Natco PharmaNATCOPHARM | ₹851.65 -2.15 (0.25%) | 15,284.34 | 13.35 | 1.66 |